Gastrointestinal Microbiome Signatures of Pediatric Patients With Irritable Bowel Syndrome
Background & Aims
The intestinal microbiomes of healthy children and pediatric patients with irritable bowel syndrome (IBS) are not well defined. Studies in adults have indicated that the gastrointestinal microbiota could be involved in IBS.
Methods
We analyzed 71 samples from 22 children with IBS (pediatric Rome III criteria) and 22 healthy children, ages 7–12 years, by 16S ribosomal RNA gene sequencing, with an average of 54,287 reads/stool sample (average 454 read length = 503 bases). Data were analyzed using phylogenetic-based clustering (Unifrac), or an operational taxonomic unit (OTU) approach using a supervised machine learning tool (randomForest). Most samples were also hybridized to a microarray that can detect 8741 bacterial taxa (16S rRNA PhyloChip).
Results
Microbiomes associated with pediatric IBS were characterized by a significantly greater percentage of the class γ-proteobacteria (0.07% vs 0.89% of total bacteria, respectively; P < .05); 1 prominent component of this group was Haemophilus parainfluenzae. Differences highlighted by 454 sequencing were confirmed by high-resolution PhyloChip analysis. Using supervised learning techniques, we were able to classify different subtypes of IBS with a success rate of 98.5%, using limited sets of discriminant bacterial species. A novel Ruminococcus-like microbe was associated with IBS, indicating the potential utility of microbe discovery for gastrointestinal disorders. A greater frequency of pain correlated with an increased abundance of several bacterial taxa from the genus Alistipes.
Conclusions
Using16S metagenomics by PhyloChip DNA hybridization and deep 454 pyrosequencing, we associated specific microbiome signatures with pediatric IBS. These findings indicate the important association between gastrointestinal microbes and IBS in children; these approaches might be used in diagnosis of functional bowel disorders in pediatric patients.
Keywords: 16S rRNA , Functional Abdominal Pain , PhyloChip , 454 Sequencing
Abbreviations used in this paper: FAP, functional abdominal pain , GI, gastrointestinal , HM, high-medium group , HMP, Human Microbiome Project , IBS-C, IBS with constipation , IBS-D, IBS with diarrhea , IBS-M, IBS-mixed , IBS-U, unsubtyped IBS , LO, low group , OTU, operational taxonomic unit , RAP, recurrent abdominal pain , rRNA, ribosomal RNA , SIBO, small intestinal bacterial overgrowth
To access this article, please choose from the options below
Conflicts of interest The authors disclose the following: Versalovic serves on an advisory board for Danone and he receives unrestricted research support from Biogaia AB. The remaining authors disclose no conflicts.
Funding Supported by the National Institute of Diabetes, Digestive and Kidney Diseases (NIDDK) and the National Center for Complementary and Alternative Medicine (NCCAM) from the National Institute of Health (NIH) (grant UH2 DK083990-01 and UH3 DK083990-02). The work in J.V.'s laboratory is supported by NIDDK (R01 DK065075 and P30 DK56338), NIH National Center for Complementary and Alternative Medicine (R01 AT004326 and R21 AT003102), and NHGRI (HMP sampling Jumpstart 5U54 HG003273-08, with R.G. as principal investigator). S.V.L. is supported by the Rainin Foundation.
PII: S0016-5085(11)00922-X
doi:10.1053/j.gastro.2011.06.072
© 2011 AGA Institute. Published by Elsevier Inc. All rights reserved.

